Sat May 31 07:20:00 UTC 2025: Okay, here’s a summary of the provided text, followed by a news article based on it:
**Summary:**
STAT, a news publication focusing on life sciences, highlights Ed Silverman, its senior writer and Pharmalot columnist, who has decades of experience covering the pharmaceutical industry. STAT also encourages readers to share news of personnel changes within their companies for publication. This week’s highlight is Nicholas Botwood’s appointment as Head of R&D and Chief Medical Officer at Syndax Pharmaceuticals, following his previous role at Bristol Myers Squibb. The full story and other industry updates are available to STAT+ subscribers.
**News Article:**
**Syndax Pharmaceuticals Taps Former Bristol Myers Squibb Exec as R&D Head and Chief Medical Officer**
BOSTON, MA – Syndax Pharmaceuticals has announced the appointment of Nicholas Botwood as its new Head of Research and Development and Chief Medical Officer. Botwood brings a wealth of experience to the role, having previously served as Senior Vice President, Head of Worldwide Medical Oncology at Bristol Myers Squibb.
The news was highlighted by STAT, a leading publication covering the life sciences industry. STAT regularly features personnel changes within the pharmaceutical and biotech sectors.
Readers interested in learning more about this appointment and other drug industry updates can subscribe to STAT+.
**Ed Silverman, Senior Writer and Pharmalot Columnist, continues to provide in-depth coverage of the pharmaceutical industry**
For nearly three decades, Ed Silverman has been covering the pharmaceutical industry, and is the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter
First Piper 